163 related articles for article (PubMed ID: 9310952)
1. Antibodies to desmin identify the blastemal component of nephroblastoma.
Folpe AL; Patterson K; Gown AM
Mod Pathol; 1997 Sep; 10(9):895-900. PubMed ID: 9310952
[TBL] [Abstract][Full Text] [Related]
2. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood.
Wang NP; Marx J; McNutt MA; Rutledge JC; Gown AM
Am J Pathol; 1995 Dec; 147(6):1799-810. PubMed ID: 7495304
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
Paner GP; McKenney JK; Epstein JI; Amin MB
Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility.
Dias P; Parham DM; Shapiro DN; Tapscott SJ; Houghton PJ
Cancer Res; 1992 Dec; 52(23):6431-9. PubMed ID: 1384962
[TBL] [Abstract][Full Text] [Related]
5. Does alveolar soft-part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression.
Wang NP; Bacchi CE; Jiang JJ; McNutt MA; Gown AM
Mod Pathol; 1996 May; 9(5):496-506. PubMed ID: 8733764
[TBL] [Abstract][Full Text] [Related]
6. Myogenin--a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1.
Michelagnoli MP; Burchill SA; Cullinane C; Selby PJ; Lewis IJ
Med Pediatr Oncol; 2003 Jan; 40(1):1-8. PubMed ID: 12426678
[TBL] [Abstract][Full Text] [Related]
7. Tenosynovial giant cell tumors: evidence for a desmin-positive dendritic cell subpopulation.
Folpe AL; Weiss SW; Fletcher CD; Gown AM
Mod Pathol; 1998 Oct; 11(10):939-44. PubMed ID: 9796719
[TBL] [Abstract][Full Text] [Related]
8. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract.
Riedlinger WF; Kozakewich HP; Vargas SO
Pediatr Dev Pathol; 2005; 8(4):427-34. PubMed ID: 16220232
[TBL] [Abstract][Full Text] [Related]
9. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract.
Riedlinger WF; Kozakewich HP; Vargas SO
Pediatr Dev Pathol; 2005; 8(3):355-61. PubMed ID: 16010486
[TBL] [Abstract][Full Text] [Related]
10. Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications.
Godbole P; Outram A; Wilcox DT; Duffy PG; Sebire NJ
J Urol; 2006 Oct; 176(4 Pt 2):1751-4. PubMed ID: 16945640
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic pitfalls of differentiating desmoplastic small round cell tumor (DSRCT) from Wilms tumor (WT): overlapping morphologic and immunohistochemical features.
Arnold MA; Schoenfield L; Limketkai BN; Arnold CA
Am J Surg Pathol; 2014 Sep; 38(9):1220-6. PubMed ID: 24832162
[TBL] [Abstract][Full Text] [Related]
12. PAX2 expression in Wilms tumors and other childhood neoplasms.
Davis JL; Matsumura L; Weeks DA; Troxell ML
Am J Surg Pathol; 2011 Aug; 35(8):1186-94. PubMed ID: 21730820
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of New Monoclonal Anti-MyoD1 (MX049) for the Diagnosis of Rhabdomyosarcoma: Comparison with 5.8A, EP212, Anti-Desmin, Anti-Myogenin, and Fluorescence
He Y; Chen X; Yu X
Ann Clin Lab Sci; 2020 May; 50(3):412-416. PubMed ID: 32581037
[TBL] [Abstract][Full Text] [Related]
14. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
[TBL] [Abstract][Full Text] [Related]
15. The expression pattern of contractile and intermediate filament proteins in developing skeletal muscle and rhabdomyosarcoma of childhood: diagnostic and prognostic utility.
Wijnaendts LC; van der Linden JC; van Unnik AJ; Delemarre JF; Voute PA; Meijer CJ
J Pathol; 1994 Dec; 174(4):283-92. PubMed ID: 7884590
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma.
Cui S; Hano H; Harada T; Takai S; Masui F; Ushigome S
Pathol Int; 1999 Jan; 49(1):62-8. PubMed ID: 10227726
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers.
Furlong MA; Mentzel T; Fanburg-Smith JC
Mod Pathol; 2001 Jun; 14(6):595-603. PubMed ID: 11406662
[TBL] [Abstract][Full Text] [Related]
18. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.
Kumar S; Perlman E; Harris CA; Raffeld M; Tsokos M
Mod Pathol; 2000 Sep; 13(9):988-93. PubMed ID: 11007039
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
20. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]